VitaNova Life Sciences (VNOV) Operating Expenses (2017 - 2026)

VitaNova Life Sciences has disclosed Operating Expenses across 10 years of filings, most recently posting $152683.0 for Q3 2026.

• Operating Expenses for Q3 2026 came in at $152683.0, up 50.84% year-over-year; the trailing twelve-month figure through Jul 2026 was $958450.0 (up 173.82% YoY), and the FY2026 annual result was $906988.0, up 146.87% from the prior year.
• Operating Expenses for Q3 2026 stood at $152683.0, down from $374522.0 in the prior quarter.
• Across five years, Operating Expenses topped out at $374522.0 in Q2 2026 and bottomed at $7385.0 in Q2 2023.
• Average Operating Expenses over 5 years is $92329.8, with a median of $75137.0 recorded in 2025.
• The widest annual swing landed in 2023, when Operating Expenses slumped 89.72%; it then jumped 1510.4% in 2024.
• Year by year, Operating Expenses stood at $7399.0 in 2022, then advanced by 18.33% to $8755.0 in 2023, then surged by 964.92% to $93234.0 in 2024, then surged by 73.36% to $161633.0 in 2025, then dropped by 5.54% to $152683.0 in 2026.
• The last three Operating Expenses figures came in at $152683.0 (Q3 2026), $374522.0 (Q2 2026), and $269612.0 (Q1 2026), per Business Quant data.